Sandra Reis is the founder and principal of RRC. Since 2003, she has been providing strategic regulatory guidance to the pharmaceutical and medical device industries, resulting in the reduction of product time-to-market. 

Sandra has planned and attended many critical path regulatory milestone meetings with Health Canada, the US Food and Drug Administration (FDA), and the European Medicines Agency (EMA), and has facilitated timely approvals through effective communication and well-written regulatory dossiers.

She enjoys the challenge of interpreting complex regulatory requirements and advising clients on all aspects of product lifecycle, from early development through to commercialization and beyond.  She has acted as an integral team member for many of her clients and understands that trust is fundamental to successful partnerships. 

Sandra holds a B.Sc. (Biology) from the University of Winnipeg and a post-graduate certificate in Pharmaceutical Regulatory Affairs and Quality Operations from Seneca College.  She is a member of the Canadian Association of Professionals in Regulatory Affairs (CAPRA), the Regulatory Affairs Professionals Society (RAPS) and the Pharmaceutical Sciences Groups (PSG).